Balanced rearrangements involving the lysine methyltransferase 2a gene (KMT2A, previously known as MLL), located on chromosome band 11q23.3, have been described in 3–6% of adult patients with de novo AML [6–11]. Here, KMT2A is linked to acute myeloid leukemia.